title: Systemic amyloidosis in a patient with hypogammaglobulinaemia.
abstract: A 49-year-old patient with an 18-year history of hypogammaglobulinaemia presented with nephrotic syndrome due to systemic amyloidosis. Recurrent infections as a consequence of an inadequate gammaglobulin substitution therapy were regarded as the main reason for the development of amyloidosis. When a high-dose intravenous immunoglobulin therapy was started, the clinical symptoms declined and the patient felt moderately well. Later the patient developed symmetrical polyarthritis clinically suggestive of rheumatoid arthritis. Although the incidence of arthritis is increased in hypogammaglobulinaemia, arthritis has not been reported in any of the few previously described patients with hypogammaglobulinaemia-associated amyloidosis. Moreover, this case provides further evidence that, in these patients, the amyloid fibrils may be of the AA type.
authors.affiliation: Department of Medicine, University of Turku, Finland.
authors.forename: P
authors.initials: P
authors.lastname: Kotilainen
authors.forename: K
authors.initials: K
authors.lastname: Vuori
authors.forename: L
authors.initials: L
authors.lastname: Kainulainen
authors.forename: H
authors.initials: H
authors.lastname: Aho
authors.forename: R
authors.initials: R
authors.lastname: Saario
authors.forename: M
authors.initials: M
authors.lastname: Asola
authors.forename: J
authors.initials: J
authors.lastname: Nikoskelainen
mesh_terms: D000361:Agammaglobulinemia / Q000150:complications* / Q000473:pathology / Q000628:therapy; D000686:Amyloidosis / Q000150:complications*; D005260:Female; D006801:Humans; D008875:Middle Aged; D009404:Nephrotic Syndrome / Q000209:etiology*; D005719:gamma-Globulins / Q000008:administration & dosage*
chemical_list: D005719:gamma-Globulins